BioLife Corporate Profile
Financials
2020 Annual Revenue
$30.28 Billion
2020 Gross Profit
$20.25 Billion
2020 Annual Net Income
$407.05 Million
2020 Number of Stores
150
2020 Revenue Growth
60.04%
Credit Rating
Leases guaranteed by Baxalta, Inc., which senior unsecured notes are Investment Grade BBB+
BioLife Corporate Profile
Baxalta is a bio-pharmaceutical company which was founded in 2015. That same year, Baxalta was acquired by Shire PLC (SHPGF), a biotechnology company focused on serving people with rare diseases and other specialized conditions worldwide. The company markets its products through wholesalers, distributors, and pharmacies.